Verrica Pharmaceuticals Inc. Skyrocketed
Fri, Dec 15, 2023 at 07:25 PM
Verrica Pharmaceuticals Inc. (VRCA:NASDAQ) rocketted at $6.09, a gain of 62%. On Fri, Dec 15, 2023, VRCA:NASDAQ touched a New 2-Week High of $6.09. The stock got featured on our News Catalysts scanner on Fri, Dec 15, 2023 at 07:52 AM in the 'BIOTECH' category. From Fri, Dec 01, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Fri, Jul 21, 2023 at $7.76 with a volume of 1M+.
About Verrica Pharmaceuticals Inc. (VRCA:NASDAQ)
Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.
Top 10 Gainers:
- Signature Bank (SBNY:NASDAQ), 149.88%
- Getaround Inc. (GETR:NYSE), 84.85%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Battalion Oil Corporation (BATL:NYSEMKT), 81.8%
- Baudax Bio, Inc. (BXRX:NASDAQ), 65.05%
- Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 61.97%
- Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 51.16%
- Brilliant Acquisition Corporation (BRLI:NASDAQ), 50%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 45.34%
- Northann Corp. (NCL:NYSEMKT), 42.14%